Last reviewed · How we verify
Nebulized lidocaine and dexmedetomidine
Nebulized lidocaine provides local anesthesia of the airway while dexmedetomidine acts as a selective alpha-2 adrenergic agonist to produce sedation and analgesia.
Nebulized lidocaine provides local anesthesia of the airway while dexmedetomidine acts as a selective alpha-2 adrenergic agonist to produce sedation and analgesia. Used for Airway anesthesia and sedation for intubation procedures, Sedation and analgesia during bronchoscopy and airway manipulation.
At a glance
| Generic name | Nebulized lidocaine and dexmedetomidine |
|---|---|
| Also known as | Combined lidocaine and dexmedetomidine group |
| Sponsor | Ain Shams University |
| Drug class | Local anesthetic and sedative-analgesic combination |
| Target | Voltage-gated sodium channels (lidocaine); alpha-2 adrenergic receptors (dexmedetomidine) |
| Modality | Small molecule |
| Therapeutic area | Anesthesia and critical care |
| Phase | FDA-approved |
Mechanism of action
Lidocaine blocks sodium channels in nerve fibers, numbing the respiratory tract to reduce cough and airway discomfort. Dexmedetomidine binds to alpha-2 adrenergic receptors in the central nervous system, producing sedation, analgesia, and anxiolysis while maintaining airway reflexes. The combination is used to facilitate airway procedures and reduce patient discomfort during intubation or bronchoscopy.
Approved indications
- Airway anesthesia and sedation for intubation procedures
- Sedation and analgesia during bronchoscopy and airway instrumentation
Common side effects
- Hypotension
- Bradycardia
- Dry mouth
- Sedation
- Local airway irritation
Key clinical trials
- Nebulized Dexmedetomidine or Lidocaine for Treatment of Post Dural Puncture Headache in Parturients Undergoing Elective Cesarean Section Under Spinal Anesthesia (EARLY_PHASE1)
- Effect of Nebulized Dexmedetomidine on Post-dural Puncture Headache (NA)
- Dexmedetomidine or Lidocaine for Lessening the Hemodynamic Responses to Laryngoscopy and Intubation (NA)
- Nebulization Versus Spray-as-You-Go Airway Topical Anesthesia Using Dexmedetomidine and Lidocaine Mixture During Awake Flexible Fiberoptic Intubation in Temporomandibular Ankylosis (NA)
- A Comparative Study to Measure the Effect of Nebulized Dexmedetomidine (PHASE3)
- Nebulized Lidocaine, Dexmedetomedine and Their Combination in Direct Laryngoscopy Surgery (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Nebulized lidocaine and dexmedetomidine CI brief — competitive landscape report
- Nebulized lidocaine and dexmedetomidine updates RSS · CI watch RSS
- Ain Shams University portfolio CI